Lactobacillus reuteri DSM 17938
Lactobacillus reuteri DSM 17938 is a dietary supplement with 19 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 14 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
3
Mid Stage
8
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
93.3%
14 of 15 finished
6.7%
1 ended early
0
trials recruiting
19
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
The Effects of Probiotic Supplementation on State and Trait Stress, Anxiety, and Depression Symptoms in Stressed Adults
Effect of Lactobacillus Reuteri DSM17938 in Neonates Treated With Antibiotics
Lactobacillus Reuteri Versus Placebo in the Treatment and Prevention of Infantile Colic
Effect of Lactobacillus Reuteri DSM 17938 to Prevent Antibiotic-associated Diarrhea in Children
The Role of Lactobacillus Reuteri in Preventing Necrotizing Enterocolitis (NEC) in Pre-term Infants
Clinical Trials (19)
The Effects of Probiotic Supplementation on State and Trait Stress, Anxiety, and Depression Symptoms in Stressed Adults
Effect of Lactobacillus Reuteri DSM17938 in Neonates Treated With Antibiotics
Lactobacillus Reuteri Versus Placebo in the Treatment and Prevention of Infantile Colic
Effect of Lactobacillus Reuteri DSM 17938 to Prevent Antibiotic-associated Diarrhea in Children
The Role of Lactobacillus Reuteri in Preventing Necrotizing Enterocolitis (NEC) in Pre-term Infants
Probiotics for Girls With Recurring Urinary Tract Infections
Metabolic Control Before and After Supplementation With Lactobacillus Reuteri DSM 17938 in Type 2 Diabetes Patients
Efficacy of Lactobacillus Reuteri DSM 17938 for the Treatment of Acute Gastroenteritis in Children
Synbiotic, Prebiotics and Probiotics in Children With Cerebral Palsy and Constipation
Lactobacillus Reuteri DSM 17938 in the Prevention of Antibiotic-associated Diarrhea in Children: Protocol of a Randomized Controlled Trial
Safety and Efficacy of Probiotics in Bangladeshi Infants
Prevention of Colic With the Probiotic Lactobacillus Reuteri
Lactobacillus Reuteri DSM 17938 in Preventing Nosocomial Diarrhea in Children
Effect of Probiotic Supplementation on Immune Function in Healthy Infants
Efficacy of a Dietary Supplementation With Lactobacillus Reuteri for Digestive Health in an Elderly Population
Study to Demonstrate the Safety of a Novel Powder Formulation of Lactobacilli in Adults
Lactobacillus Reuteri for the Treatment of Infantile Colic:
Lactobacillus Reuteri in Children With Constipation
L Reuteri for the Prevention of Nosocomial Diarrhea
All 19 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 19